Analysis of Responses to Valerian Root Extract in the Feline Pulmonary Vascular Bed

Journal of Alternative and Complementary Medicine

Volumn 9, Issue 6, 2003, Pages 909-918

  Fields, Aaron M ^a   Richards, Todd A ^b   Felton, Jason A ^c   Felton, Shaili K ^d   Bayer, Erin Z ^e   Ibrahim, Ikhlass N ^e   Kaye, Alan David ^e  

^a FLUSHING HOSPITAL MEDICAL CENTER   (United States)

^b STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^c SAINT LOUIS UNIVERSITY HOSPITAL   (United States)

^d BARNES JEWISH HOSPITAL   (United States)

^e TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 AMINOPROPYL(METHYL)PHOSPHINIC ACID; 4 AMINOBUTYRIC ACID RECEPTOR BLOCKING AGENT; ACETYLCHOLINE; ADENOSINE TRIPHOSPHATE; ARACHIDONIC ACID; BICUCULLINE; BRADYKININ; GLIBENCLAMIDE; MECLOFENAMIC ACID; MUSCIMOL; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE INHIBITOR; PINACIDIL; SACLOFEN; VALERIAN;

ANALYTIC METHOD; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL REACTIVITY; BLOOD VESSEL TONE; CAT; CONTROLLED STUDY; DRUG EFFECT; ENZYME INHIBITION; HERBAL MEDICINE; LUNG BLOOD VESSEL; LUNG VASCULAR RESISTANCE; NONHUMAN; PLANT ROOT; PRIORITY JOURNAL; VASCULAR SMOOTH MUSCLE; VASODILATATION;

EID: 0347989518     PISSN: 10755535     EISSN: None     Source Type: Journal    
DOI: 10.1089/107555303771952253     Document Type: Article

References (21)

1. Anwar N, Mason D. Two actions of gamma-aminobutyric acid on the responses of the isolated basilar artery from the rabbit. Br J Pharmacol 1982;75:177-181.
2. Barrett B, Kiefer D, Rabago D. Assessing the risks and benefits of herbal medicine: An overview of scientific evidence. Altern Ther Health Medicine 1999;5:40-49.
3. Bribes E, Casellas P, Vidal H, Dussossoy D, Casellas D. Peripheral benzodiazepine receptor mapping in rat kidney. Effects of angiotensin II-induced hypertension. J Am Soc Nephrol 2002;13:1-9.
4. Castelli M, Ingianni A, Stefanini E, Gessa G. Distribution of GABA(B) receptor mRNAs in the rat brain and peripheral organs. Life Sci 1999;64:1321-1328.
5. Cavadas C, Araujo I, Cotrim MD, Amaral T, Cunha P, Macedo T, Ribeiro C. In vitro study on the interaction of Valeriana officinalis. L. extracts and their amino acids on GABAA receptor in rat brain. Arzneimittelforschung 1995;45:753-755.
6. Chapman R, Hey J, Rizzo C, Bolser D. GABAB receptors in the lung. Trends Pharmacol Sci 1993;14:26-29.
7. Collins I, Moyes C, Davey W, Rowley M, Bromidge F, Quirk K, Atack J, McKernan R, Thompson S, Wafford K, Dawson G, Pike A, Sohal B, Tsou N, Ball R, Castro J. 3-Heteroaryl-2-pyridones: Benzodiazepine site ligands with functional delectivity for alpha 2/alpha 3-subtypes of human GABA(A) receptor-ion channels. J Med Chem 2002;45:1887-1900.
8. Dorn M. Efficacy and tolerability of baldrian versus oxazepam in non-organic and non-psychiatric insomniacs: A randomized, double-blind, clinical, comparative study. Forsch Komplementarmed Klass Naturheilkd 2000;7:79-84.
9. Dunaev V, Trzhetsinskii S, Tishkin V, Fursa N, Linenko V. Biological activity of the sum of the valepotriates isolated from Valeriana alliariifolia. Farmakol Toksikol 1987;50:33-37.
10. French J, Rapoport R, Matlib M. Possible mechanism of benzodiazepine-induced relaxation of vascular smooth muscle. J Cardiovasc Pharmacol 1989;14:405-411.
11. Houghton P. The scientific basis for the reputed activity of valerian. J Pharm Pharmacol 1999;51:505-512.
12. Kaye AD, Clarke RC, Sabar R, Vig S, Dhawan KP, Hofbauer R, Kaye AM: Herbal medicines: Current trends in anesthesiology practice-A hospital survey. J Clin Anesth 2000;12:468-471.
13. Mak J, Barnes P. Peripheral type benzodiazepine receptors in human and guinea pig lung: Characterization and autoradiographic mapping. J Pharmacol Exp Ther 1990;252:880-885.
14. Miller L. Herbal medicinals: Selected clinical considerations focusing on known or potential drug-herb interactions. Arch Intern Med 1999;159:1142-1143.
15. Ong J, Kerr D. GABA-receptors in peripheral tissues Life Sci 1990;46:1489-1501.
16. Ortiz J, Nieves-Natal J, Chavez P. Effects of Valeriana officinalis extracts on [3H] flunitrazepam binding, synaptosomal [3H] GABA uptake, and hippocampal [3H] GABA release. Neurochem Res 1999;24:1373-1378.
17. Pinn G. Herbal medicine. What is the evidence? Aust Fam Physician 2001;30:1154-1159.
18. Santos M, Ferreira F, Cunha A, Carvalho A, Ribeiro C, Macedo T. Synaptosomal GABA release as influenced by valerian root extract-Involvement of the GABA carrier. Arch Int Pharmacodyn Ther 1994;327:220-231.
19. Schmitz M, Jackel M. Comparative study for assessing quality of life of patients with exogenous sleep disorders (temporary sleep onset and sleep interruption disorders) treated with a hops-valarian preparation and a benzodiazepine drug. Wien Med Wochenschr 1998;148:291-298.
20. Vonderheid-Guth, B, Todorova A, Brattstrom W, Dimpfel A. Pharmacodynamic effects of valerian and hops extract combination (Ze 91019) on the quantitative-topographical EEG in healthy volunteers. Eur J Med Res 2000;5:139-144.
21. Yokota K, Tatebayashi H, Matsuo T, Shoge T, Motomura H, Matsuno T, Fukuda A, Tashiro N. The effects of neuroleptics on the GABA-induced Cl(-) current in rat dorsal root ganglion neurons: Differences between some neuroleptics. Br J Pharmacol 2002;135:1547-1555.